Article Figures & Data
Tables
Respondent Characteristic No. (%) Professional role (n = 642) Attending, faculty or community physician 460 (71.7) Resident 122 (19.0) PA or NP 50 (7.8) Other 10 (1.6) Medical specialty (n = 519) Family medicine 495 (95.4) Othera 24 (4.6) Primary setting (n = 607) FQHC or similar 165 (27.2) Hospital-owned practice 161 (26.5) Private practice 134 (22.1) Academic medical center 83 (13.7) Other 64 (10.5) Years since training (n = 626) 0 73 (11.7) 1-5 130 (20.8) 6-10 153 (24.4) 11-15 109 (17.4) 16-20 28 (4.5) >20 104 (16.6) NA 29 (4.6) Payer mix >25% of patients have Medicare (n = 610) 403 (66.0) >25% of patients have Medicaid (n = 609) 318 (52.2) >25% of patients have private insurance (n = 609) 341 (55.9) >25% of patients have no insurance (n = 590) 77 (13.0) Practice region (n = 632) West 317 (50.1) South 141 (22.2) Midwest 107 (17.0) Northeast 64 (10.2) US Territory 3 (0.5) Miles from endocrinologist (n = 614) ≤10 405 (66.0) 11-40 102 (16.6) >40 107 (17.4) Diabetes care & education resource access Diabetes care and education specialist within practice (at least part-time) (n = 614) 221 (36.0) Can refer to diabetes care and education specialist within 10 miles (n = 612) 498 (81.4) Can refer to other diabetes education resources within 10 miles (n = 613) 454 (74.1) Experience with CGM (n = 629) I have never heard of CGM 6 (1.0) I have heard of CGM, but I have never had patients on it 87 (13.8) I have had patients on CGM, but I have never prescribed it 293 (46.6) I have prescribed a CGM 243 (38.6) Likelihood to prescribe CGM (n = 603) Not at all likely 40 (6.6) Somewhat likely 187 (31.0) Moderately likely 168 (27.9) Very likely 208 (34.5) Moderately/very likely to prescribe CGM with access to resources Consultation on insurance issues (n = 603) 434 (72.0) CGM education/training workshop (n = 603) 436 (72.3) One-time consult with endocrinologist (n = 602) 380 (63.1) Virtual specialty care center to refer patients for direct support (n = 602) 379 (63.0) Educational website about CGM (n = 603) 375 (62.2) Telementoring sessions with specialty team (n = 603) 372 (61.7) Asynchronous e-consultations with an endocrinologist (n = 604) 324 (53.6) CGM = continuous glucose monitoring; FQHC = federally qualified health center; NA = not applicable; NP = nurse practitioner; PA = physician assistant.
↵a General internal medicine, internal medicine-pediatrics, pediatrics.
Characteristic OR (95% CI) P Value Respondent role <.001 Physician Ref. Resident 0.30 (0.16-0.58) PA or NP 0.36 (0.16-0.77) Primary setting .13 Private practice Ref. Academic medical center 1.42 (0.73-2.76) FQHC/similar 0.88 (0.50-1.53) Hospital-owned 1.39 (0.84-2.29) Other 1.82 (0.93-3.57) Employment .04 Full-time or resident Ref. Part-time 0.55 (0.30-0.98) Time primary care, % .03 ≥75 Ref. <75 0.60 (0.37-0.96) Miles from endocrinologist .03 ≤10 Ref. 11-40 0.95 (0.58-1.53) >40 1.94 (1.17-3.21) CGM = continuous glucose monitoring; FQHC = federally qualified health center; NP = nurse practitioner; PA = physician assistant.
Note: C-statistic = 0.688. Years since training and payer mix did not meet threshold for inclusion in final model.
- Table 3.
Respondent and Practice Characteristics and Future Likelihood to Prescribe CGM (N = 570)
Characteristic OR (95% CI) P Value Previously prescribed CGM 7.44 (4.80-11.53) <.001 Miles from endocrinologist .17 ≤10 Ref. 11-40 0.76 (0.46-1.25) >40 1.43 (0.83-2.46) Patients with medicare, % .004 ≤25 Ref. 26-50 1.37 (0.89-2.10) >50 2.67 (1.50-4.78) Patients with medicaid, % .08 ≤25 Ref. 26-50 0.63 (0.41-0.98) >50 1.04 (0.62-1.75) CGM = continuous glucose monitoring.
Note: C-statistic = 0.756. Respondent role, primary setting, part or full-time employment, years since training, percent of patients using private insurance, and percent of patients with no insurance did not meet threshold for inclusion in final model.
Additional Files
SUPPLEMENTAL DATA IN PDF FILE BELOW